Journals / The Anatolian Journal of Cardiology / 2016 / Cilt: 16 - Sayı: 12

Serum nitric oxide levels in patients with coronary artery ectasia

Pages
947–952
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results of the multivariate regression analysis, LDL and NO levels were identified as independent factors associated with CAE (OR=1.02, 95% CI 1–1.04, p=0.02 and OR=0.88, 95% CI 0.83–0.93, p=0.001, respectively).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Serum levels of nitric oxide (NO) are decreased in patients with atherosclerosis and also are a risk factor for the development of atherosclerosis.
📊
Key Findings & Data:The purpose of this clinical trial was to determine the relationship between CAE and serum NO levels.Methods: This prospective controlled study was conducted between January 2008 and March 2012.
💡
Conclusion & Impact:According to the results of the multivariate regression analysis, LDL and NO levels were identified as independent factors associated with CAE (OR=1.02, 95% CI 1–1.04, p=0.02 and OR=0.88, 95% CI 0.83–0.93, p=0.001, respectively).
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Serum levels of nitric oxide (NO) are decreased in patients with atherosclerosis and also are a risk factor for the development of atherosclerosis. Endothelial dysfunction and diffuse atherosclerosis have been proposed for the etiology of coronary artery ectasia (CAE). The purpose of this clinical trial was to determine the relationship between CAE and serum NO levels.Methods: This prospective controlled study was conducted between January 2008 and March 2012. Serum levels of NO were compared in 40 patients with CAE (mean age 60.1±7.3 years) and 40 patients with normal coronary arteries (mean age 57.6±5 years) as a control group. CAE was diagnosed when a segment of coronary artery was more than 1.5 times the diameter of the adjacent healthy segment. Patients with stenotic atherosclerotic plaques, slow coronary flow, previous history of revascularization, acute coronary syndromes, left ventricular dysfunction, valvular heart disease, and systemic diseases were not included in the study. The effect of NO on the outcome was studied by constructing a receiver operating characteristic (ROC) curve with CAE as the primary variable. Effects of different variables on CAE were calculated using binary logistics regression analysis.Results: Serum NO concentrations were significantly lower in patients with CAE than in the control group (42.1±20.1 μmol/L vs. 77.3±15.7 μmol/L, p< 0.001). According to the results of the multivariate regression analysis, LDL and NO levels were identified as independent factors associated with CAE (OR=1.02, 95% CI 1–1.04, p=0.02 and OR=0.88, 95% CI 0.83–0.93, p=0.001, respectively). ROC analysis revealed that using a cut-off point of 63.3, NO level predicts CAE with a sensitivity of 87.5% and specificity of 90%.Conclusion: Our study indicates that decreased levels of NO are present in patients with CAE compared to patients with normal coronary arteries, supporting the hypothesis that decreased levels of NO might be associated with CAE development

🔖

Cite This Article

GÜRLEK, A., ESENBOĞA, K., ÖZCAN, Ö. U., ÇİÇEK, Ö. F., AYRAL, P. A., KAVAS, G. Ö., EROL, Ç. (2016). Serum nitric oxide levels in patients with coronary artery ectasia. The Anatolian Journal of Cardiology, Cilt: 16 - Sayı: 12, 947–952. https://ajindex.com/articles/366738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Seabra-Gomes R, Somerville J, Ross DN, Emanuel R, Parker DJ, Wong M. Congenital coronary artery aneurysms. Br Heart J 1974; 36: 329-35
  2. Hartnell GG, Parnell BM, Pridie RB. Coronary artery ectasia. Its prevalence and clinical significance in 4993 patients. Br Heart J 1985; 54: 392-5
  3. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary artery ectasia. Am J Cardiol 1976; 37: 217-22
  4. Oliveros RA, Falsetti HL, Carroll RJ, Heinle RA, Ryan GF. Arteriosclerotic coronary artery aneurysm. Report of five cases and a review of the literature. Arch Intern Med 1974; 134: 1072-6
  5. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, et al. Aneurysmal coronary artery disease. Circulation 1983; 67: 134-8
  6. Kruger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exerciseinduced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronopathy”). J Am Coll Cardiol 1999; 34: 1461-70
  7. Swanton RH, Thomas ML, Coltart DJ, Jenkins BS, Webb-Peploe MM, Williams BT. Coronary artery ectasia- a variant of occlusive coronary arteriosclerosis. Br Heart J 1978; 40: 393-400
  8. Befeler B, Aranda J, Embi A, Mullin FL, El-Sherif N, Lazzara R. Coronary artery aneurysms: study of the etiology, clinical course and effect on left ventricular function and prognosis. Am J Med 1977; 62: 597-607
  9. Schoenhagen P, Ziada KM, Vince DG, Nissen SE, Tuzcu EM. Arterial remodeling and coronary artery disease: The concept of “dilated” versus “obstructive” coronary atherosclerosis. J Am Coll Cardiol 2001; 38: 297-306
  10. Sanyal S, Caccavo N. Is nitroglycerin detrimental in patients with coronary artery ectasia? A case report. Tex Heart Inst J 1998; 25: 140-4
  11. Mrdovic I, Jozic T, Asanin M, Perunicic J, Ostojic M. Myocardial reinfarction in a patient with coronary ectasia. Cardiology 2004; 102: 32-4
  12. Rosenberg VD, Nepomnyashchikh LM. Pathomorphological peculiarities of coronary artery ectasias and their role in the pathogenesis of sudden cardiac death. Bull Exp Biol Med 2004; 138: 515-21
  13. Vincent MA, Montagnani M, Quon MJ. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium. Curr Diab Rep 2003; 3: 279-88
  14. Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms. Biochem Biophys Res Commun 2000; 279: 412-9
  15. Furchgott RF, Zawadz